Company Filing History:
1 out of 75 
1 out of 1,974 
Years Active: 2020
Title: Wibke Deisting: Innovator in Antibody Constructs
Introduction
Wibke Deisting is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibody constructs. His work focuses on innovative solutions that have the potential to impact medical treatments.
Latest Patents
Wibke Deisting holds a patent for "Antibody constructs for CD70 and CD3." This invention relates to a bispecific antibody construct that includes a first binding domain targeting human CD70 on the surface of a target cell and a second binding domain that binds to human CD3 on the surface of a T cell. The patent also encompasses a polynucleotide encoding the antibody construct, a vector containing the polynucleotide, and a host cell transformed or transfected with the polynucleotide or vector. Additionally, the invention outlines a process for producing the antibody construct, its medical uses, and a kit that includes the antibody construct. He has 1 patent to his name.
Career Highlights
Wibke Deisting has worked with prominent companies in the biotechnology sector, including Amgen Research (Munich) GmbH and Amgen Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Wibke's notable coworkers include Tobias Raum and Claudia Blümel, who have also made significant contributions to the field of biotechnology.
Conclusion
Wibke Deisting's innovative work in antibody constructs showcases his commitment to advancing medical science. His contributions have the potential to lead to new therapeutic approaches in treating diseases.